质母细胞瘤治疗策略的发展:传统方法和新型干预措施
Chirag Shetty1, Rajesh Tamatta1, Namdev Dhas2
1Manipal Centre for Biotherapeutics Research, Manipal Academy of Higher Education, Manipal, India.
3 Biotech
|September 2, 2025
概括
质母细胞瘤 (GBM) 是一种侵袭性脑瘤. 免疫疗法和纳米技术等新疗法有望改善质母细胞瘤治疗和患者生存率.
科学领域:
- 神经瘤学
- 分子生物学
- 癌症治疗方法
背景情况:
- 质母细胞瘤 (GBM) 是最具攻击性的原发性脑瘤.
- 它的特点是快速生长,扩散透和对常规疗法的耐药性.
- 目前的治疗提供了有限的生存期,平均15-18个月.
研究的目的:
- 审查GBM的病理生理学,分子机制和治疗进展.
- 探索克服治疗耐药性的新策略,改善患者的治疗结果.
- 突出需要多模式治疗方法.
主要方法:
- 关于质母细胞瘤病理学和治疗的综合文献综述.
- 分子亚型的分析及其对预后的影响.
- 评估包括免疫疗法,瘤病毒疗法和纳米技术在内的新疗法.
主要成果:
- GBM 是高度异质的,具有明显的分子亚型.
- 免疫疗法和基于纳米技术的药物输送等新兴疗法显示出潜力.
- 仍然存在挑战,包括免疫抑制瘤微环境和跨越血脑屏障的药物输送.
结论:
- 迫切需要将新疗法与标准治疗结合起来.
- 基于分子分析的个性化药物对于改善质母细胞瘤的结果至关重要.
- 未来的研究必须集中在克服耐药性和增强药物输送系统上.
相关概念视频
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


